SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
25-Jan-24 7:40 PM View: | Arcus Biosciences, Inc. (RCUS) | 23-Jan-24 | Grant | 21,300 | -- | -- | 41% 51.83K to 73.13K | |
04-Jan-24 5:23 PM View: | Arcus Biosciences, Inc. (RCUS) | 02-Jan-24 | Sale (Planned) | 2,004 | $20.00 | $40,080.00 | (4%) 53.84K to 51.83K | |
20-Dec-23 4:10 PM View: | Arcus Biosciences, Inc. (RCUS) | 19-Dec-23 | Disposition | 2,808 | $18.09 | $50,796.70 | (5%) 56.64K to 53.84K | |
20-Dec-23 4:10 PM View: | Arcus Biosciences, Inc. (RCUS) | 18-Dec-23 | Disposition | 2,749 | $17.74 | $48,767.30 | (5%) 59.39K to 56.64K | |
09-Jun-23 4:05 PM View: | Arcus Biosciences, Inc. (RCUS) | 07-Jun-23 | Sale (Planned) | 4,049 | $20.04 | $81,142.00 | (6%) 63.44K to 59.39K | |
25-Jan-23 5:53 PM View: | Arcus Biosciences, Inc. (RCUS) | 23-Jan-23 | Grant | 34,000 | -- | -- | 115% 29.44K to 63.44K | |
16-Dec-22 9:44 PM View: | Arcus Biosciences, Inc. (RCUS) | 16-Dec-22 | Sale | 2,453 | $30.75 | $75,429.60 | (17%) 14.02K to 11.57K | |
10-Mar-22 5:08 PM View: | Arcus Biosciences, Inc. (RCUS) | 08-Mar-22 | Grant | 15,500 | -- | -- | 221% 7.02K to 22.52K | |
20-Dec-21 4:22 PM View: | Arcus Biosciences, Inc. (RCUS) | 17-Dec-21 | Market Sale | 621 | $40.36 | $25,060.80 | (8%) 7.64K to 7.02K | (3%) |
20-Dec-21 4:22 PM View: | Arcus Biosciences, Inc. (RCUS) | 16-Dec-21 | Market Sale | 485 | $39.83 | $19,315.20 | (6%) 8.13K to 7.64K | (4%) |
20-Jan-21 4:10 PM View: | Arcus Biosciences, Inc. (RCUS) | 19-Jan-21 | Grant | 12,500 | -- | -- | 250% 5.0K to 17.5K | |
09-Sep-20 4:53 PM View: | Arcus Biosciences, Inc. (RCUS) | 09-Sep-20 | Market Purchase | 5,000 | $21.57 | $107,848.00 | 100% 0 to 5.0K | 42% |
24-Jun-20 5:03 PM View: | Unity Biotechnology, Inc. (UBX) | 22-Jun-20 | Payment of Exercise | 2,483 | $9.67 | $24,010.60 | (2%) 163.51K to 161.03K | 42% |
01-Apr-20 5:16 PM View: | Unity Biotechnology, Inc. (UBX) | 30-Mar-20 | Grant | 29,106 | -- | -- | 22% 134.4K to 163.51K | |
26-Feb-20 5:48 PM View: | Unity Biotechnology, Inc. (UBX) | 24-Feb-20 | Option Exercise | 10,000 | $3.43 | $34,300.00 | 8% 124.4K to 134.4K | |
24-Jun-19 4:17 PM View: | Unity Biotechnology, Inc. (UBX) | 20-Jun-19 | Grant | 21,075 | -- | -- | 20% 103.33K to 124.4K | |
12-Oct-18 5:36 PM View: | Unity Biotechnology, Inc. (UBX) | 10-Oct-18 | Option Exercise | 5,000 | $3.43 | $17,150.00 | 5% 96.35K to 101.35K | |
07-May-18 6:24 PM View: | Unity Biotechnology, Inc. (UBX) | 07-May-18 | Conversion | 1,630 | -- | -- | 2% 94.72K to 96.35K | |
16-May-17 4:57 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 12-May-17 | Option Exercise | 19,967 | $5.54 | $110,700.00 | 156% 12.79K to 32.76K | |
11-Apr-17 12:51 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 10-Apr-17 | Option Exercise | 3,000 | $4.47 | $13,418.40 | 31% 9.79K to 12.79K | |
21-Mar-17 6:05 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 20-Mar-17 | Option Exercise | 21,517 | $4.47 | $96,241.20 | 220% 9.79K to 31.31K | |
21-Mar-17 6:05 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 20-Mar-17 | Market Option Sale (Planned) | 21,517 | $19.81 | $426,340.00 | (69%) 31.31K to 9.79K | 61% |
09-Mar-17 7:22 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 09-Mar-17 | Option Exercise | 2,500 | $4.47 | $11,182.00 | 34% 7.29K to 9.79K | |
01-Dec-16 7:01 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 30-Nov-16 | Grant | 1,289 | $9.10 | $11,723.50 | 21% 6.0K to 7.29K | |
03-Oct-16 2:32 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 29-Sep-16 | Option Exercise | 4,000 | $4.47 | $17,891.20 | 200% 2.0K to 6.0K | |
13-May-16 4:05 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 12-May-16 | Option Exercise | 2,000 | $4.47 | $8,945.60 | 100% 0 to 2.0K |